MarkAllenSandersDO
Family Medicine • Fort Worth, TXGeriatric Medicine, Hospice & Palliative Medicine
Physician
Dr. Sanders is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3437 W 7th St
Fort Worth, TX 76107Phone+1 817-688-1588Fax+1 817-423-7361
Education & Training
Texas College of Osteopathic MedicineClass of 1998
Certifications & Licensure
IL State License 2012 - 2026
LA State License 2020 - 2025
TX State License 2000 - 2025
AL State License 2016 - 2024
Clinical Trials
- Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers Start of enrollment: 2005 Jul 01
- Diagnosing Adverse Drug Reactions Registry Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- 25 citationsInsulin degradation by acinar cell proteases creates a dysfunctional environment for human islets before/after transplantation: benefits of α-1 antitrypsin treatment.Gopalakrishnan Loganathan, Rajinder K. Dawra, Subbiah Pugazhenthi, Zhiguang Guo, Sajjad M. Soltani
Transplantation. 2011-12-15 - 18 citationsCulture of impure human islet fractions in the presence of alpha-1 antitrypsin prevents insulin cleavage and improves islet recovery.Gopalakrishnan Loganathan, Rajinder K. Dawra, Subbiah Pugazhenthi, Alexander C. Wiseman, Mark A. Sanders
Transplantation Proceedings. 2010-07-01 - 66 citationsIdentification and characterization of a small molecule inhibitor of Fatty Acid binding proteins.Ann V. Hertzel, Kristina Hellberg, Joseph M. Reynolds, Andrew C. Kruse, Brittany E. Juhlmann
Journal of Medicinal Chemistry. 2009-10-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
